Its finances slightly more secure, Elan plans to push a new Alzheimer's vaccine into clinical trials.
FORBES: Use Widening For Alzheimer's Drugs
2.
Investors apparently expected information about a new anti-Alzheimer's antibody or a new version of an Alzheimer's vaccine that was pulled from clinical trials after it caused brain problems.
FORBES: Elan, ImClone Lose, Celgene Wins
3.
The Alzheimer's vaccine, code-named AN-1792, was in midstage clinical trials.